ArticleClinical and experimental medicine2026
Application of a machine learning model integrating T cell subsets and clinical markers in 28-Day mortality prediction of sepsis patients.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To develop a machine learning-based prediction model that integrating T cell subset data with clinical features to predict the 28-day mortality risk in sepsis patients. A retrospective cohort study was conducted using the MIMIC-IV database. Collected data included demographics, T cell subsets, laboratory results, SOFA score, GCS, and 28-day mortality. Feature selection was performed using LASSO regression combined with 10-fold cross-validation. We compared the performance of six machine learning models, namely RF, SVM, XGB, GLM, GBM, and LASSO logistic regression. Model performance was evaluated using the AUROC, calibration curves, and DCA, while the SHAP method was employed to interpret the optimal model. A total of 781 sepsis patients were included in our study, with a 28-day mortality rate of 18.5%. LASSO regression identified 12 key features: Age, CD + 4 Count, CD8 + T cell count, lactate, platelet, albumin, Na+, Bun, heart rate, anion gap, eosinophil count, monocyte count. Among the six compared machine learning models, GLM achieved the best comprehensive performance in the testing set, with an AUROC of 0.720, good calibration (Brier score: 0.134). SHAP analysis clarified the contribution degree and direction of each predictive factor to the model output. A GLM model integrating T cell subsets (notably CD8 + T cell count) and clinical features was successfully constructed. The model showed moderate discriminative ability and potential clinical application value in predicting the 28-day mortality risk of sepsis. SHAP-based interpretability clarifies individual risk factors, serving as an auxiliary prognostic tool for clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.